To test the concept of what we term Synthetic Antigen Receptor (SAR)-MSCs, we functionalized MSCs with Ab, targeting the epidermal growth factor receptor (EGFR), whose overexpression is implicated in the pathogenesis of several malignancies, including non-small-cell lung cancer (NSCLC) [23]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.